Patent · US Expired

Yeast strains possessing the interrupted ATF2 gene and their applications

US6503749B2 · kind B2 · utility

4Cited by

0References

1Claims

0Family size

Assignee

AVENTIS PHARMA S.A. · FR

Inventors

Tilman Achstetter · Oberkirch, DE
Gilles Cauet · Thonon-les-Bains, FR
Eric Degryse · Strasbourg, FR

Key dates

Filing date	Mar 1, 2001
Grant date	Jan 7, 2003
Priority date	—
Expiry date	Mar 1, 2021

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12P33/00
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

A subject of the invention is a modified yeast strain in which the acetyl-CoA pregnenolone acetyltransferase (APAT) activity is eliminated by altering the gene coding for this activity with resultant stabilization of 3&bgr;-hydroxysteroids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.